Exchange Traded Concepts LLC Sells 755 Shares of McKesson Corporation $MCK

Exchange Traded Concepts LLC lowered its position in shares of McKesson Corporation (NYSE:MCK) by 19.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,101 shares of the company’s stock after selling 755 shares during the quarter. Exchange Traded Concepts LLC’s holdings in McKesson were worth $2,544,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of MCK. Brighton Jones LLC boosted its position in shares of McKesson by 46.3% during the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock worth $1,438,000 after purchasing an additional 798 shares in the last quarter. Caxton Associates LLP bought a new stake in shares of McKesson in the 1st quarter valued at $233,000. Sivia Capital Partners LLC raised its stake in McKesson by 77.9% during the 2nd quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock worth $502,000 after buying an additional 300 shares during the period. American Century Companies Inc. raised its stake in McKesson by 16.0% during the 2nd quarter. American Century Companies Inc. now owns 13,718 shares of the company’s stock worth $10,052,000 after buying an additional 1,895 shares during the period. Finally, Loomis Sayles & Co. L P bought a new position in McKesson during the second quarter worth about $39,000. Institutional investors own 85.07% of the company’s stock.

Analyst Upgrades and Downgrades

MCK has been the subject of a number of research analyst reports. JPMorgan Chase & Co. boosted their target price on McKesson from $983.00 to $1,107.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of McKesson in a research report on Wednesday, December 10th. Barclays boosted their price objective on McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a research report on Wednesday, February 18th. Leerink Partners reissued an “outperform” rating and set a $1,085.00 target price on shares of McKesson in a research note on Thursday, March 5th. Finally, Mizuho raised their target price on shares of McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a report on Thursday, February 5th. Thirteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, McKesson has a consensus rating of “Moderate Buy” and a consensus price target of $960.93.

Insider Activity

In other McKesson news, EVP Michele Lau sold 2,725 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the completion of the transaction, the executive vice president owned 3,247 shares of the company’s stock, valued at $3,214,530. This represents a 45.63% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Leann B. Smith sold 190 shares of the firm’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total transaction of $179,550.00. Following the transaction, the executive vice president directly owned 2,989 shares of the company’s stock, valued at $2,824,605. This represents a 5.98% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 3,868 shares of company stock worth $3,743,820. 0.08% of the stock is currently owned by insiders.

McKesson Trading Up 0.6%

MCK stock opened at $864.99 on Wednesday. The stock has a 50-day moving average price of $908.89 and a two-hundred day moving average price of $842.77. McKesson Corporation has a 1 year low of $637.00 and a 1 year high of $999.00. The stock has a market cap of $105.95 billion, a PE ratio of 24.88, a price-to-earnings-growth ratio of 1.38 and a beta of 0.38.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. The company had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The company’s quarterly revenue was up 11.4% compared to the same quarter last year. During the same period in the previous year, the company posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, analysts forecast that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be paid a $0.82 dividend. The ex-dividend date is Monday, March 2nd. This represents a $3.28 annualized dividend and a yield of 0.4%. McKesson’s payout ratio is presently 9.43%.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.